OSU Center Lands $11.3M for Thyroid Cancer Risk Studies, Resource Cores | GenomeWeb

NEW YORK (GenomeWeb News) – Investigators at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) have reeled in an $11.3 million grant from the National Cancer Institute to pursue genome-focused thyroid cancer studies and to fund shared core resources.

Specifically, the NCI funding will support a study that launched in 2008 called "Genetic and Signaling Pathways in Epithelial Thyroid Cancer," which has four integrated components.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.